Interventionelle Behandlung der Aortenklappe – Update und Herausforderungen 2019

2019 ◽  
Vol 144 (22) ◽  
pp. 1547-1552
Author(s):  
Muhammed Gerçek ◽  
Tanja Rudolph ◽  
Sabine Bleiziffer ◽  
Volker Rudolph

AbstractAortic valve stenosis is the most common valvular heart disease requiring treatment in Europe. Transcatheter aortic valve implantation (TAVI) has already been established as a standard therapy in patients with high but also intermediate risk.In the meantime, it is even being performed more frequently than surgical replacement in Germany.This article presents current data, indications and future challenges.

Author(s):  
Jonathon P. Fanning ◽  
Allan J. Wesley ◽  
Darren L. Walters ◽  
Eamonn M. Eeles ◽  
Adrian G. Barnett ◽  
...  

2015 ◽  
Vol 10 (2) ◽  
pp. 103 ◽  
Author(s):  
Jose John ◽  
Richardt Gert ◽  
Abdel-Wahab Mohamed ◽  
◽  
◽  
...  

Transcatheter aortic valve implantation (TAVI) has become an effective treatment option for patients with severe aortic stenosis and high surgical risk or contraindications for surgical aortic valve replacement. Most of the currently available prostheses employ either balloon-expandable or self-expandable designs. Presently, there is a paucity of data directly comparing these two widely used prosthesis types. Forthcoming trials will reveal whether newer designs of both technologies translate into fewer complications and better outcomes, with expansion of TAVI indications. This manuscript reviews features and clinical outcomes of balloon- and self-expanding prostheses, summarising current data from registries and trials.


Sign in / Sign up

Export Citation Format

Share Document